The British journal of nutrition · 2025
Triceps skinfold thickness is associated with all-cause mortality independent of BMI among maintenance haemodialysis patients.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Yaya, Huang Yan, Zhong Qiuxia, Xia Chaoying, Wang Jieyu, Lan Xiaolei, Kong Yaozhong, Wan Qijun, Li Yumin, Huang Sheng, Liu Yan, Liu Aiqun, Liu Fanna, Qin Xianhui, Li Youbao, Liang Min
Аннотация
Triceps skinfold thickness (TSF) is a surrogate marker of subcutaneous fat. Evidence is limited about the association of sex-specific TSF with the risk of all-cause mortality among maintenance haemodialysis (MHD) patients. We aimed to investigate the longitudinal relationship of TSF with all-cause mortality among MHD patients. A multicenter prospective cohort study was performed on 1034 patients undergoing MHD. The primary outcome was all-cause mortality. The median (interquartile range) of TSF was 9·7 (6·3-13·3 mm) in males and 12·7 (10·0-18·0 mm) in females. Over a median follow-up of 4·4 years (interquartile range, 2·4-7·9 years), there were 548 (53·0 %) deaths. When TSF was assessed as sex-specific quartiles, compared with those in quartile 1, the adjusted hazard ratio (HR) (95 % CI) of all-cause mortality in quartile 2, quartile 3 and quartile 4 was 0·93 (0·73, 1·19), 0·75 (0·58, 0·97) and 0·69 (0·52, 0·92), respectively (P for trend = 0·005). Moreover, when analysed by sex, increased TSF (≥9·7 mm for males and ≥18 mm for females) was significantly associated with a reduced risk of all-cause mortality (quartile 3-4 v. quartile 1-2; HR, 0·70; 95 % CI: 0·55, 0·90 in males; quartile 4 v. quartile 1-3; HR, 0·69; 95 % CI: 0·48, 1·00 in females). In conclusion, high TSF was significantly associated with a lower risk of all-cause mortality in MHD patients.